Lonza

In News

Microsize, Schedio link to buy Lonza’s Swiss micronization plant - Fierce Pharma

Fierce Pharma - Dec 01, 2025

Lone Star, Altaris, One Rock Said Among Bidders for Lonza Assets - Bloomberg.com

Bloomberg.com - Nov 19, 2025

Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland - Business Wire

Business Wire - Nov 24, 2025

Lonza Group (OTCMKTS:LZAGY) Sees Strong Trading Volume - Time to Buy? - MarketBeat

MarketBeat - Dec 03, 2025

Lonza head of bioscience talks recent Redberry acquisition - BioProcess International

BioProcess International - Nov 05, 2025

Lonza confirms outlook as it expects more contracts in coming months - Reuters

Reuters - Oct 23, 2025

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) - the-scientist.com

the-scientist.com - Oct 16, 2025

On the fast track to the clinic: early decisions in drug development - Labiotech.eu

Labiotech.eu - Nov 18, 2025

Jason Berndt ’01 Joins Lonza as New Head of Group Operations, Executive VP - West Point Association of Graduates

West Point Association of Graduates - Sep 20, 2025

Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing - DCAT Value Chain Insights

DCAT Value Chain Insights - Apr 03, 2025

Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Sep 23, 2025

Lonza to expand bioscience testing offering with the acquisition of Redberry - Drug Discovery News

Drug Discovery News - Oct 27, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment